Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone implant for relapse prevention after opioid detoxification
CTR20261528Phase 4Active
- Sponsor
- Shenzhen Sciencare Medical Industries Co., Ltd.
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone in opioid use disorder (OUD), sponsored by Shenzhen Sciencare Medical Industries Co., Ltd.. Started Apr 2026; status: active.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on CTR20261528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261528.